Skip to main content
ATR
NYSE Industrial Applications And Services

AptarGroup Reports Mixed 2025 Results with Increased Sales & EPS, Higher Debt, and New Share Buyback Program

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$133.17
Mkt Cap
$8.739B
52W Low
$103.227
52W High
$164.28
52W Position info
29% above low
Off High info
19% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ATR sits 29% above its 52-week low of $103.227.

Summary

AptarGroup's 2025 annual report shows increased sales and EPS, but also a significant rise in debt and a drop in operating cash flow. The company announced a new, substantial share repurchase program and disclosed new legal challenges.


Key Events · Earnings and Guidance · ATR

  • Mixed Financial Performance

    Net sales increased 5% to $3.78 billion, and diluted EPS rose 6.5% to $5.89 for the fiscal year 2025. However, net cash provided by operations decreased by 11.4% to $570.0 million.

  • Significant Capital Allocation

    The company returned $485.8 million to shareholders in 2025 through dividends and $365.0 million in share repurchases. The Board approved a new share repurchase authorization of up to $600.0 million, replacing previous authorizations.

  • Increased Financial Leverage

    Total debt increased significantly by 44.5% to $1.48 billion from $1.03 billion in 2024, leading to an increase in the Net Debt to Net Capital ratio from 24.4% to 28.6%.

  • New Legal Proceedings Disclosed

    The company disclosed two new lawsuits initiated in 2025: an antitrust claim and patent infringement actions. Management believes these will not have a material adverse effect, but the possible loss or range of loss is currently unquantifiable.


Analysis · ATR · Industrial Applications And Services

AptarGroup's 2025 annual report reveals a mixed financial performance, with positive growth in net sales and diluted EPS, alongside a notable increase in total debt and a decline in operational cash flow. The company demonstrated a commitment to shareholder returns through a substantial share repurchase program and a new, larger authorization. However, new legal proceedings introduce unquantified risks, and the increase in leverage warrants investor attention. The Q1 2026 EPS guidance provides a forward-looking perspective on expected performance.

At the time of this filing, ATR was trading at $133.17 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $103.23 to $164.28. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATR - Latest Insights

ATR
Apr 30, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $123.68
Real-time Price: $132.36 info
Change: +$8.68 (+7%) info
Market Cap: $8.447B info
ATR
Apr 30, 2026, 5:16 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $123.68
Real-time Price: $132.36 info
Change: +$8.68 (+7%) info
Market Cap: $8.447B info
ATR
Apr 30, 2026, 5:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $123.68
Real-time Price: $132.36 info
Change: +$8.68 (+7%) info
Market Cap: $8.447B info
ATR
Mar 27, 2026, 8:08 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $124.69
Real-time Price: $132.36 info
Change: +$7.67 (+6%) info
Market Cap: $8.447B info
ATR
Mar 17, 2026, 5:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $129.50
Real-time Price: $132.36 info
Change: +$2.86 (+2%) info
Market Cap: $8.447B info